We are live on ! Find out more
GF

Gabelli Funds Portfolio holdings

AUM $14.8B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$14.1B
AUM Growth
+$963M
Cap. Flow
-$36.3M
Cap. Flow %
-0.26%
Top 10 Hldgs %
12.86%
Holding
1,287
New
192
Increased
280
Reduced
411
Closed
65

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$28.6M
2
BPMC
Blueprint Medicines
BPMC
+$21.9M
3
SKX
Skechers
SKX
+$16.9M
4
FARO
Faro Technologies
FARO
+$14M
5
DNB
Dun & Bradstreet
DNB
+$13M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$43M
2
BECN
Beacon Roofing Supply, Inc.
BECN
+$20.6M
3
DFS
Discover Financial Services
DFS
+$18M
4
FNA
Paragon 28, Inc.
FNA
+$16.8M
5
NEM icon
Newmont
NEM
+$16.2M

Sector Composition

Rank Sector Weight
1 Industrials 20.94%
2 Financials 12.8%
3 Communication Services 10.31%
4 Technology 10.08%
5 Utilities 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WFC icon
51
Wells Fargo
WFC
$261B
$60.1M 0.43%
750,199
-79,816
-10% -$5.75M
XYL icon
52
Xylem
XYL
$28.5B
$60.1M 0.43%
464,600
-7,425
-2% -$899K
HRI icon
53
Herc Holdings
HRI
$5.43B
$59.5M 0.42%
451,946
+16,896
+4% +$2.05M
ROL icon
54
Rollins
ROL
$18.6B
$55.2M 0.39%
977,700
-269,000
-22% -$15.1M
PM icon
55
Philip Morris
PM
$301B
$53.8M 0.38%
295,350
– –
AN icon
56
AutoNation
AN
$6.97B
$52.8M 0.38%
265,950
-12,450
-4% -$2.25M
GGG icon
57
Graco
GGG
$12.9B
$52.6M 0.37%
612,300
-15,000
-2% -$1.24M
DEO icon
58
Diageo
DEO
$46.2B
$52.5M 0.37%
520,850
-22,500
-4% -$2.44M
FCX icon
59
Freeport-McMoran
FCX
$90B
$52.2M 0.37%
1,204,760
-70,456
-6% -$2.68M
ES icon
60
Eversource Energy
ES
$28.2B
$50.7M 0.36%
796,250
-16,700
-2% -$1.03M
CW icon
61
Curtiss-Wright
CW
$27.7B
$50.2M 0.36%
102,836
-1,700
-2% -$671K
STT icon
62
State Street
STT
$50.9B
$49M 0.35%
461,088
-18,810
-4% -$1.74M
OGE icon
63
OGE Energy
OGE
$10.3B
$49M 0.35%
1,104,400
-2,600
-0.2% -$115K
MDLZ icon
64
Mondelez International
MDLZ
$77.7B
$47.8M 0.34%
708,150
-22,600
-3% -$1.51M
CVX icon
65
Chevron
CVX
$388B
$47.3M 0.34%
330,350
+18,349
+6% +$2.59M
FNV icon
66
Franco-Nevada
FNV
$41.4B
$47.1M 0.33%
287,223
-637
-0.2% -$105K
HES
67
DELISTED
Hess
HES
$47M 0.33%
339,400
+2,600
+0.8% +$351K
AEE icon
68
Ameren
AEE
$31.5B
$46.9M 0.33%
488,050
-6,800
-1% -$660K
DCI icon
69
Donaldson
DCI
$10.8B
$45.8M 0.33%
660,650
-6,500
-1% -$437K
COP icon
70
ConocoPhillips
COP
$147B
$45.1M 0.32%
502,730
-31,700
-6% -$2.85M
AD
71
Array Digital Infrastructure
AD
$3.02B
$45.1M 0.32%
704,322
-22,330
-3% -$1.42M
GEV icon
72
GE Vernova
GEV
$270B
$44.7M 0.32%
84,431
+3,616
+4% +$1.51M
TMUS icon
73
T-Mobile US
TMUS
$193B
$44.4M 0.32%
186,544
-1,600
-0.9% -$391K
RHP icon
74
Ryman Hospitality Properties
RHP
$8.4B
$42.7M 0.3%
432,300
-4,900
-1% -$458K
WTS icon
75
Watts Water Technologies
WTS
$11.5B
$42.6M 0.3%
173,100
-8,600
-5% -$1.93M
1 2
3
4 5

Similar funds

FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
CCM
Cantillon Capital Management New York $15.1B AUM 23.54% 1-Year Est. Return
AT
AMF Tjänstepension Stockholm, Sweden $15.1B AUM 30.1% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $15.1B AUM 26.53% 1-Year Est. Return

Gabelli Funds's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli Funds held 1,287 positions worth $14.1B, up 7.3% from $13.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Gabelli Funds's Q2 2025 filing shows 192 new, 280 increased, 411 reduced and 65 closed positions. Its largest new stake was Blueprint Medicines: 211,169 shares worth $27.1M. The largest sale was Intra-Cellular Therapies Inc., an estimated $43M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

  • Gabelli Funds's largest Q2 2025 buy was Blueprint Medicines: 211,169 shares worth $27.1M.
  • Gabelli Funds added most to SpringWorks Therapeutics in Q2 2025, an estimated $28.6M increase.
  • Gabelli Funds's biggest Q2 2025 reduction was Newmont, cutting an estimated $16.2M.
  • Gabelli Funds fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $43M.
  • Gabelli Funds's ten largest holdings make up 13% of its $14.1B portfolio in Q2 2025.
  • Gabelli Funds opened 192 new positions and closed 65 in Q2 2025.
  • Gabelli Funds's portfolio value rose 7.3% quarter-over-quarter to $14.1B.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.